Navigation Links
Echo Therapeutics to Present at the Oppenheimer Healthcare Conference
Date:12/7/2011

PHILADELPHIA, Dec. 7, 2011 /PRNewswire/ -- Echo Therapeutics, Inc. (NASDAQ: ECTE), a company developing its needle-free Symphony® tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude® SkinPrep System for transdermal drug delivery, today announced that Patrick T. Mooney, M.D., Chairman & CEO of Echo Therapeutics, will present at the Oppenheimer 22nd Annual Healthcare Conference.

Dr. Mooney will make a presentation to prospective corporate partners and investors on Wednesday, December 14th at 3:20 PM ET.  The Company's presentation will be delivered at the Waldorf Astoria Hotel in New York City.  

About Echo Therapeutics

Echo is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in hospital critical care units. Echo is also developing its needle-free Prelude SkinPrep System as a platform technology for enhanced skin permeation for delivery of topical pharmaceuticals.

For More Information:
Christine Olimpio
Director, Investor Relations & Corporate Communications
(215) 717-4104


'/>"/>
SOURCE Echo Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Pepscan Therapeutics Presents Protein Mimicry Platform for the Discovery of anti-GPCR Antibodies at International Antibody Conference
2. ViroPharma and Halozyme Therapeutics Announce Positive Data From Initial Phase 2 Assessment of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Hyaluronidase (rHuPH20)
3. Echo Therapeutics Announces Pricing of $5.4 Million Registered Direct Equity Financing
4. FDA Sets April 24, 2012 as PDUFA Goal Date for Cell Therapeutics Resubmitted Pixantrone New Drug Application
5. GiiResearch.com: Polycystic Ovarian Syndrome (PCOS) Therapeutics - Market to Witness Static Growth Until 2018
6. Novelos Therapeutics Prices $5.9 Million Public Offering
7. Unigenes Proprietary Peptelligence™ Platform Used to Commence Cara Therapeutics Phase 1 Clinical Trial of Oral Novel Peripherally-Acting Kappa Opioid Agonist
8. Antiviral Therapeutics - Technologies, Markets and Companies
9. Pain Management Therapeutics Market to 2017 - Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta
10. Cara Therapeutics Initiates Phase I Study with Oral Formulation of Novel Peripherally-Acting Kappa Opioid Agonist
11. Amsterdam Molecular Therapeutics Receives Orphan Designation in the European Union for Hemophilia B Gene Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... -- Registration is officially open for MEDTEC China South 2015, ... Shenzhen Convention & Exhibition Center. The Shenzhen ... the MEDTEC China family of events. MEDTEC China South, an ... serve the South China market through ... region for China,s medical device industry. ...
(Date:3/3/2015)... 2015  RedHill Biopharma Ltd. (NASDAQ/TASE: RDHL) ... company primarily focused on late clinical-stage, proprietary, ... including gastrointestinal cancers, today announced that ... will be presenting at VirtualInvestorConferences.com, a live ... 5, 2015, at 10:00 am EST. ...
(Date:3/3/2015)... , March 3, 2015 - ... 26 June 2015, SNIEC, Shanghai, China ... 10th P-MEC China, will be held at Shanghai New International ... P-MEC China originated from CPhI Worldwide and was introduced to ... important bridge between Chinese pharmaceutical companies and global pharmaceutical industry ...
Breaking Medicine Technology:Pre-registration Open for 2015 MEDTEC China South 2Pre-registration Open for 2015 MEDTEC China South 3RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 2RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 3RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 415th Anniversary, Be Part of Chinese Pharma Dream 215th Anniversary, Be Part of Chinese Pharma Dream 3
... board of directors of Eli Lilly and Company (NYSE: LLY ... $0.49 a share on outstanding common stock. This is the same dividend ... the total annual dividend for 2011 to $1.96 per share. ... the close of business on November 15, 2011. About ...
... Verisk Health ... Solutions suite to include greater predictive power and reporting ... International Classification of Diseases, Tenth Revision, Clinical Modification ... models that predict emergency department (ED) utilization and measure practice ...
Cached Medicine Technology:Verisk Health's DxCG Risk Solutions Technology Ready to Support Industry Adoption of ICD-10-CM 2
(Date:3/3/2015)... The number of couples experiencing infertility in ... This increases to 50% by the time a woman ... AA, et al. Estimating the prevalence of infertility in ... a reproductive endocrinologist and co-director at Olive Fertility Centre, ... director and founder of Acubalance Wellness Centre will be ...
(Date:3/3/2015)... The North America application delivery ... $1,224.6 million to $1,694.6 million, at a ... , Browse through the TOC of North ... analysis of industry trends and segments, with ... http://www.micromarketmonitor.com/market/north-america-application-delivery-network-adn-7381582251.html , An application delivery ...
(Date:3/3/2015)... 2015 Splashtop Inc. , the ... is now available for Epson® MoverioTM BT-200 smart glasses. ... Moverio Apps Market , iPod, iPhone, and iPad users ... the Epson Moverio smart glasses using Mirroring360, enhancing the ... , The Epson smart glasses have an advanced binocular ...
(Date:3/3/2015)... 2015 OncLive® and Indiana University ... forces to share news about the center’s research ... is part of OncLive’s Strategic Alliance Partnership initiative. ... and marketing teams will partner with the IU ... center, to highlight accomplishments. They include the center’s ...
(Date:3/3/2015)... 03, 2015 Celestix Networks, the ... today announced the global availability of Celestix Cloud ... the world’s most deployed platform for DirectAccess and ... R2. This new release enables organizations to manage ... from a single HTML 5 web interface called ...
Breaking Medicine News(10 mins):Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 2Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 3Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 4Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 2Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 3Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 2Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 3Health News:IU Simon Cancer Center Teams with OncLive® in Strategic Alliance Partnership 2Health News:IU Simon Cancer Center Teams with OncLive® in Strategic Alliance Partnership 3Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 2Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 3
... 1, 2008 -- 11 a.m. news event -- Hall of ... DC 20001 , , WASHINGTON, ... coming together to outline the current fiscal situation states are ... a recovery package that will spur job growth, support infrastructure ...
... 1 An independent study at the,University of Cumbria found that ... same time as exercising. The games reduce the boredom of,exercise. , ... 12 were asked to use exercise equipment,combined with video games provided ... The children could play their games only while they maintained ...
... Calif., Dec. 1 Transcept Pharmaceuticals,Inc., a privately-held specialty ... Chief Executive Officer, is scheduled to,participate at the RBC ... a panel entitled "Delivering Novel Drug Solutions: The Future ... place on Thursday, December,11, 2008 at 1:30 PM Eastern ...
... Ohio and TAMPA, Fla., Dec. 1 Cardinal,Health and ... agreement to offer surgical kits that include disposable health,care ... from SRI,Surgical. , ... SRI,Surgical,s complete line of more than 400 disposable surgical ...
... can prevent spread of infection , , MONDAY, Dec. 1 (HealthDay ... and older for HIV, says a new practice guideline released ... the virus that causes AIDS. , In the United ... 20,000 new infections are caused each year by people who ...
... Acuo Technologies(R), developers,of high-performance software for intelligent ... announced the contracting with Rush,University Medical ... neutral archiving,solution which becomes the basis of the ... is based on the Acuo Technologies DICOM,Services Grid(TM) ...
Cached Medicine News:Health News:Governors, Legislators Update Current State Fiscal Conditions, Push for Economic Recovery Package from Congress, President-elect 2Health News:Children Tell Researchers: We'll Get Fit if It's Fun 2Health News:Transcept Pharmaceuticals to Participate on Drug Delivery Investor Panel 2Health News:Cardinal Health, SRI Surgical Sign Five-Year Agreement For Surgical Kits 2Health News:Cardinal Health, SRI Surgical Sign Five-Year Agreement For Surgical Kits 3Health News:Guideline Urges HIV Tests for All Patients 13 and Older 2Health News:Acuo Technologies Announces Vendor Neutral Archiving Contract With Rush University Medical Center 2Health News:Acuo Technologies Announces Vendor Neutral Archiving Contract With Rush University Medical Center 3
... ARRAY® Multifocal IOL is a foldable silicone ... PMMA haptics and is designed to be ... The ARRAY® Multifocal IOL is the first ... first to offer patients a full range ...
... 2% Hydroxypropyl Methylcellulose solution that is especially ... volume, small incision surgery. The low molecular ... removal with minimal risk of elevated intraocular ... unobstructed view of the surgical field throughout ...
... The visco-elastic ENDOGEL is a sterile, ... hyaluronate. ENDOGEL is supplied in a ... a Luer-Lock fitting, delivering 0,85 ml. ... polysaccharide composed of repetitive chains of ...
... ophthalmic viscosurgical device ... patented HPMC viscoelastic ... performance, economy and ... properties and handling ...
Medicine Products: